The Lustgarten Foundation is the largest private funder of the world’s preeminent pancreatic cancer researchers.
To date, we have funded more than $250 million in research grants and been a leading force in every major advancement in pancreatic cancer research.
Progress is paramount. We drive bold, innovative research with the singular mission: transforming pancreatic cancer into a curable disease.
WOODBURY, NY – At the American Association for Cancer Research (AACR) Annual Meeting 2023, The Lustgarten Foundation and the AACR presented the Lustgarten Foundation-AACR Career Development Awards for Pancreatic Cancer Research, in Honor of Ruth Bader Ginsburg and John Robert Lewis to Christina M. Ferrer, PhD, from the University of Maryland, Baltimore, Maryland, and Ashley […]
WOODBURY, N.Y., May 9, 2023 — The Lustgarten Foundation has announced that the 2023 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project grants will be awarded to Karyn Goodman, MD, MS, Vice Chair of Radiation Oncology and Associate Director of Clinical Research at Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, for her study […]
In honor of Juneteenth, join us for this important webinar with discussions about clinical trial participation, Health Equity vs. Health Equality, and personal stories from the C-Suite of one of America’s best known cancer centers, along with real progress being made at a local hospital at the epicenter in the fight against cancer.
News From The Field
Using mRNA tailored to each patient’s tumor, the vaccine may have staved off the return of one of the deadliest forms of cancer in half of those who received it.
In the near future, this implantable nanofluidic device could be a game changer in treating pancreatic cancer. Nanomedicine experts at Houston Methodist Academic Institute developed the device.
The microbiome is a term used for the collection of microbes, including microorganisms like bacteria, that live on or in the human body. Jordan Kharofa, MD, said there was little known about the microbiome of long-term pancreatic cancer survivors.
From Nurse to Patient
When Susan was diagnosed with pancreatic cancer, cutting-edge drugs and a supportive medical team helped her go from patient to survivor. Now she raises funds for continued research through a Lustgarten Foundation Walk for Research.Read Susan’s Story